Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
Driving the Future of the Healthcare Supply Chain
The Milken Institute’s 2023 Future of Health Summit brought together policymakers, patient advocates, healthcare workers and other leading public health experts to discuss critical issues shaping the healthcare landscape. As part of the event, Kirk Kaminsky, HDA Chairman and McKesson President of U.S. Pharmaceutical, joined panelists to discuss the future of the healthcare supply chain.
Distributors Leading the Way in the Next Phase of COVID-19
Since the emergence of COVID-19, HDA distributor members have worked tirelessly to navigate the exceptional and unprecedented demands of this public health emergency. From managing unique inventory demands of the first hotspots, to ensuring access to emerging treatment options and testing, HDA members draw upon their extensive supply and distribution networks, logistics expertise and experience navigating public health emergencies. Moreover, distributors are committed to the public- and private-sector partnerships that are critical in combating COVID-19, fueling our recovery and improving pandemic resiliency for the future.